Seven for 2007: Seven Things You Should Know About Breast Cancer Risk, From the Harvard Women's Health Watch
Posted on: Thursday, 4 January 2007, 15:00 CST
BOSTON, Jan. 4 /PRNewswire-USNewswire/ -- There's no one big way to reduce your risk for breast cancer, but a combination of approaches could make a difference, reports the January 2007 issue of Harvard Women's Health Watch. Here are several factors that could affect your risk:
Weight gain. Studies show that weight gain is a risk factor for breast cancer after menopause. The link is estrogen, which is believed to promote the development of breast cancer. Fat tissue converts precursors in the body into estrogen, keeping the hormone in circulation even when ovarian production stops at menopause.
Alcohol. Women who consume even a few drinks per week raise their risk for breast cancer. Scientists aren't sure why; it may be that alcohol raises estrogen levels or interacts with carcinogens.
Activity level. Exercise may help prevent breast cancer and its recurrence in a few ways, including by keeping weight down and decreasing the amount of estrogen in breast tissue.
Vitamin D. There's evidence that vitamin D helps protect against several types of cancer, including breast cancer.
Hormone use. Because lifetime exposure to estrogen is a risk factor for breast cancer, there's concern about women's use of birth control pills and postmenopausal hormones. Discuss your risk with your doctor before taking these.
Breast density. Breast density is trumped only by age and certain gene mutations in the hierarchy of risk factors. Digital mammography has been shown to improve cancer detection in women with dense breasts.
Chemoprevention. Taking the anti-estrogen drug tamoxifen or raloxifene may cut the incidence of breast cancer in women at increased risk for the disease.
Also in this issue: -- Why it's hard to adopt healthy habits -- and why you should keep trying -- Multivitamins/minerals: Micronutrient insurance -- Benefits of nuts -- By the way doctor: How do I quit my antidepressant? Are generic and brand-name drugs really the same?
Harvard Women's Health Watch is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at http://www.health.harvard.edu/women or by calling 1-877-649-9457 (toll free).
Editors: For immediate release -- may be used in whole or part with attribution. Media inquiries welcome.
Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.
Harvard Health Publications
CONTACT: Christine Junge of Harvard Health Publications,+1-617-432-4717, Christine_Junge@hms.harvard.edu
Web site: http://www.health.harvard.edu/women
Source: PRNewswire-USNewswire
Related Articles
- Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women
- Breast Cancer Will Risk Increases For Smokers and Overweight Women
- Revealing Breast Cancer in Hispanic Women
- Quest Diagnostics Launches Test to Help Oncologists Predict Risk of Breast Cancer Recurrence in Women With Estrogen Receptor (ER)-Positive, Lymph Node- Negative Cancers
- Raloxifene Averts Breast Cancer, at a Risk
- No Link Between Estrogen-Only Therapy, Breast Cancer in Postmenopausal Women, Stanford Scientist Says
- Doubts About Gene Tests: A Newfound Gap in Catching Mutations for Breast Cancer May Have Women at Risk Rethinking the Options
- Gene Mutations Linked to Breast Cancer in Black Women
- ARIMIDEX(R) (Anastrozole) Gains Full FDA Approval for Adjuvant Treatment of Hormone Receptor-Positive Early Breast Cancer in Postmenopausal Women
- Cornell Breast Cancer Educator Cautions Women Against Using Herbal Supplements
 |
 |
User Comments (0)
RSS Feeds